BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28809071)

  • 21. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting.
    Khalil V; Wang W; Charlson L; Blackley S
    Int J Evid Based Healthc; 2019 Sep; 17(3):164-172. PubMed ID: 31211729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.
    Lee SH; Han CD; Yang IH; Ha CW
    J Korean Med Sci; 2011 Apr; 26(4):561-7. PubMed ID: 21468265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients' risk awareness.
    Schmitt MR; Miller MJ; Harrison DL; Farmer KC; Allison JJ; Cobaugh DJ; Saag KG
    Patient Educ Couns; 2011 Jun; 83(3):391-7. PubMed ID: 21129892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
    Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
    Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.
    Lanas A; Esplugues JV; Zapardiel J; Sobreviela E
    World J Gastroenterol; 2009 Dec; 15(47):5953-9. PubMed ID: 20014459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.
    Fry RB; Ray MN; Cobaugh DJ; Weissman NW; Kiefe CI; Shewchuk RM; Saag KG; Curtis JR; Allison JJ
    Arthritis Rheum; 2007 Dec; 57(8):1539-45. PubMed ID: 18050227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.
    Clinard F; Bardou M; Sgro C; Lefevre N; Raphael F; Paille F; Dumas M; Hillon P; Bonithon-Kopp C
    Eur J Clin Pharmacol; 2001 Dec; 57(10):737-43. PubMed ID: 11829204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.
    Meuwesen WP; du Plessis JM; Burger JR; Lubbe MS; Cockeran M
    Int J Clin Pharm; 2016 Aug; 38(4):863-9. PubMed ID: 27091130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan.
    Tsumura H; Tamura I; Tanaka H; Chinzei R; Ishida T; Masuda A; Shiomi H; Morita Y; Yoshida M; Kutsumi H; Inokuchi H; Doita M; Kurosaka M; Azuma T
    Intern Med; 2007; 46(13):927-31. PubMed ID: 17603228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk perception of NSAIDs in hospitalized patients in Greece.
    Karakitsiou M; Varga Z; Kriska M; Kristova V
    Bratisl Lek Listy; 2017; 118(7):427-430. PubMed ID: 28766354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease.
    Yang JH; Lee BH; Eum KS; Suk KS; Park JO; Kim HS; Lee HM; Moon SH
    Clin Orthop Surg; 2020 Sep; 12(3):343-352. PubMed ID: 32904035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns.
    Pattanaprateep O; McEvoy M; Attia J; Thakkinstian A
    BMC Med Inform Decis Mak; 2017 Jul; 17(1):96. PubMed ID: 28676124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.
    Gunnarsdóttir AI; Kinnear M
    Pharm World Sci; 2005 Aug; 27(4):316-20. PubMed ID: 16228631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting.
    Paul AD; Chauhan CK
    Eur J Clin Pharmacol; 2005 Feb; 60(12):889-92. PubMed ID: 15605276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints.
    Koffeman AR; Valkhoff VE; Jong GW; Warlé-van Herwaarden MF; Bindels PJ; Sturkenboom MC; Luijsterburg PA; Bierma-Zeinstra SM
    Scand J Prim Health Care; 2014 Jun; 32(2):90-8. PubMed ID: 24931511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.
    Chaiamnuay S; Allison JJ; Curtis JR
    Am J Health Syst Pharm; 2006 Oct; 63(19):1837-51. PubMed ID: 16990630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.
    Pertusi RM; Godwin KS; House JK; Knebl JA; Alexander JH; Rubin BR; Forman MD
    J Am Osteopath Assoc; 1999 Jun; 99(6):305-10. PubMed ID: 10405516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.